Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MANGALAM | NSE
-0.53
-1.87%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
27.77
28.20
28.20
27.76
Mangalam Drugs & Organics Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates at VAPI in India and internationally. It offers a range of API products which include Acyclovir Amodiaquine Artemether Artesunate Atorvastatin Calcium Atazanavir Sulfate Bisoprolol Fumarate Chloroquine Phosphate and Dolutegravir Sodium; Efavirenz Emtricitabine Furosemide Hydroxychloroquine Sulphate Lumefantrine and Nimesulide; Nitrofurantoin Anhydrous and Monohydrate; Primaquine and Piperaquine Phosphate; Pregabalin Pyrimethamine Pyronaridine Tetraphosphate and Sulfadoxine; and Tenofovir Alafenamide Hemifumarate and Disoproxil Fumarate. The company also offers intermediates comprising 2-Dibutylamino-1-(27-dichloro-9H-fluorine-4-yl)-ethanol; 46-Dichloro-5-methoxy pyrimidine; 47 Dichloroquinoline; Ortho phenoxy methane sulfonanilide; and Tenofovir Alafenamide Base and Disoproxil Base. In addition it offers specialty chemicals such as Menthol; 23-Dihydrophthalazine-1 4-dione; and 4-cynoethyl-2-methyl phenol. The company was incorporated in 1972 and is based in Mumbai India.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
15.7%1 month
45.4%3 months
51.1%6 months
64.8%-
-
1.40
0.71
0.29
21.21
0.81
-
245.56M
449.11M
4.69M
-
5.64
14.80
-12.10
-6.31
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
3.58
Range1M
6.54
Range3M
17.92
Rel. volume
0.42
Price X volume
279.81K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lasa Supergenerics Limited | LASA | Drug Manufacturers-Specialty & Generic | 8.04 | 406.53M | -4.96% | n/a | 22.84% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 21.21 | 24.85 | Par |
| Ent. to Revenue | 0.81 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 1.40 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 51.05 | 42.17 | Riskier |
| Debt to Equity | 0.71 | 0.35 | Expensive |
| Debt to Assets | 0.29 | 0.17 | Expensive |
| Market Cap | 449.11M | 290.82B | Emerging |